Methods For Treating Hair Loss Disorders - EP2635299

The patent EP2635299 was granted to The Trustees OF Columbia University IN The City OF NEW York on Jul 31, 2019. The application was originally filed on Nov 2, 2011 under application number EP11838771A. The patent is currently recorded with a legal status of "Opposition Rejected".

EP2635299

THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
Application Number
EP11838771A
Filing Date
Nov 2, 2011
Status
Opposition Rejected
Dec 22, 2023
Grant Date
Jul 31, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

CONCERT PHARMACEUTICALSApr 30, 2020DRYWOODADMISSIBLE

Patent Citations (65) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS2002000069
DESCRIPTIONUS2002077313
DESCRIPTIONUS2002173478
DESCRIPTIONUS2004018176
DESCRIPTIONUS2004057937
DESCRIPTIONUS2005009163
DESCRIPTIONUS2005272150
DESCRIPTIONUS2007072204
DESCRIPTIONUS4683195
DESCRIPTIONUS4683202
DESCRIPTIONUS4921475
DESCRIPTIONUS5008110
DESCRIPTIONUS5087240
DESCRIPTIONUS5088977
DESCRIPTIONUS5096815
DESCRIPTIONUS5163899
DESCRIPTIONUS5164189
DESCRIPTIONUS5198346
DESCRIPTIONUS5223409
DESCRIPTIONUS5236838
DESCRIPTIONUS5252479
DESCRIPTIONUS5254346
DESCRIPTIONUS5283317
DESCRIPTIONUS5290561
DESCRIPTIONUS5328470
DESCRIPTIONUS5332213
DESCRIPTIONUS5336168
DESCRIPTIONUS5352456
DESCRIPTIONUS5407713
DESCRIPTIONUS5580757
DESCRIPTIONUS5641670
DESCRIPTIONUS5712171
DESCRIPTIONUS5747469
DESCRIPTIONUS5879680
DESCRIPTIONUS6017524
DESCRIPTIONUS6083725
DESCRIPTIONUS6143290
DESCRIPTIONUS6188045
DESCRIPTIONUS6210666
DESCRIPTIONUS6395884
DESCRIPTIONUS6410010
DESCRIPTIONUS6451600
DESCRIPTIONUS6458574
DESCRIPTIONUS6461609
DESCRIPTIONUS6511847
DESCRIPTIONUS7294504
DESCRIPTIONUS7422896
DESCRIPTIONWO0001846
DESCRIPTIONWO0044895
DESCRIPTIONWO0044914
DESCRIPTIONWO0129058
DESCRIPTIONWO0132840
DESCRIPTIONWO0136646
DESCRIPTIONWO2004044188
DESCRIPTIONWO2007100870
DESCRIPTIONWO9105058
DESCRIPTIONWO9320242
DESCRIPTIONWO9418318
DESCRIPTIONWO9518972
DESCRIPTIONWO9622529
DESCRIPTIONWO9907409
DESCRIPTIONWO9932619
INTERNATIONAL-SEARCH-REPORTUS2003044803
SEARCHEP1176140
SEARCHWO2010093808

Non-Patent Literature (NPL) Citations (284) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- ABADIE, V.; SOLLID, L.M.; BARREIRO, L.B.; JABRI, B., "Integration of genetic and immunological insights into a model of celiac disease pathogenesis", Annu Rev Immunol, (20110000), vol. 29, pages 493 - 525-
DESCRIPTION- AGESTA, N.; ZABALA, R.; DIAZ-PEREZ, J.L., "Alopecia areata during interferon alpha-2b/ribavirin therapy", Dermatology, (20020000), vol. 205, pages 300 - 301-
DESCRIPTION- ALKHALIFAH, A.; ALSANTALI, A.; WANG, E.; MCELWEE, K.J.; SHAPIRO, J., "Alopecia areata update: part I. Clinical picture, histopathology, and pathogenesis", JAm Acad Dermatol, vol. 62, pages 177 - 188-
DESCRIPTION- ALKHALIFAH, A.; ALSANTALI, A.; WANG, E.; MCELWEE, K.J.; SHAPIRO, J., "Alopecia areata update: part II. Treatment", JAm Acad Dermatol, vol. 62, pages 191 - 202-
DESCRIPTION- ALTARAS et al., Adv Biochem Eng Biotechnol., (20050000), vol. 99, pages 193 - 260-
DESCRIPTION- ANDERSON et al., Science, (19920000), vol. 256, pages 808 - 813-
DESCRIPTION- ANDERSON, Nature, (19980000), vol. 392, no. 6679, pages 25 - 20-
DESCRIPTION- ANDERSSON, A.K.; SUMARIWALLA, P.F.; MCCANN, F.E.; AMJADI, P.; CHANG, C.; MCNAMEE, K.; TORNEHAVE, D.; HAASE, C.; AGERSO, H.; STENNI, "Blockade of NKG2D ameliorates disease in mice with collagen-induced arthritis: A potential pathogenic role in chronic inflammatory arthritis", Arthritis Rheum, (20110000), vol. 63, pages 2617 - 2629-
DESCRIPTION- AREA, E.; MUSABAK, U.; AKAR, A.; ERBIL, A.H.; TASTAN, H.B., "Interferon-gamma in alopecia areata", Eur J Dermatol, (20040000), vol. 14, pages 33 - 36-
DESCRIPTION- ARMSTRONG; ARMSTRONG, J Cell Biol, (19900000), vol. 110, pages 1439 - 55-
DESCRIPTION- ATHERTON et al., Solid Phase Peptide Synthesis: a Practical Approach., (19890000), no. IRL Press-
DESCRIPTION- BARRINGER, Gene, (19900000), vol. 89, page 117-
DESCRIPTION- BASS, Nature, (20010000), vol. 411, page 428 429-
DESCRIPTION- BENOIT, S.; TOKSOY, A.; GOEBELER, M.; GILLITZER, R., "Selective expression of chemokine monokine induced by interferon-gamma in alopecia areata", J Invest Dermatol, (20030000), vol. 121, pages 933 - 935-
DESCRIPTION- BERGER, Methods Enzymol., (19870000), vol. 152, pages 307 - 316-
DESCRIPTION- BHAGAT, G.; NAIYER, A.J.; SHAH, J.G.; HARPER, J.; JABRI, B.; WANG, T.C.; GREEN, P.H.; MANAVALAN, J.S., "Small intestinal CD8+TCRgammadelta+NKG2A+ intraepithelial lymphocytes have attributes of regulatory cells in patients with celiac disease", J Clin Invest, (20080000), vol. 118, pages 281 - 293-
DESCRIPTION- BICKERS DR; LIM HW; MARGOLIS D; WEINSTOCK MA; GOODMAN C; FAULKNER E; GOULD C; GEMMEN E; DALL T, "The burden of skin diseases: 2004 a joint project of the American Academy of Dermatology Association and the Society for Investigative Dermatology", JAm Acad Dermatol., (20060000), vol. 55, pages 490 - 5-
DESCRIPTION- BLONDELLE et al., Tib Tech, (19960000), vol. 14, page 60-
DESCRIPTION- BOCK et al., Nature, (19920000), vol. 355, pages 564 - 566-
DESCRIPTION- BRADSHAW, Cell Signal., (20100800), vol. 22, no. 8, pages l 175 - 84-
DESCRIPTION- BRENNER et al., Proc. Natl. Acad. Sci. USA, (19920000), vol. 89, pages 5381 - 5383-
DESCRIPTION- BROWER, Nature Biotechnology, (19980000), vol. 16, pages 1304 - 1305-
DESCRIPTION- BUCHWALD et al., Surgery, (19800000), vol. 88, page 507-
DESCRIPTION- BUNIN et al., Proc. Natl. Acad. Sci. USA, (19940000), vol. 91, pages 4708 - 4712-
DESCRIPTION- BURG, Mol. Cell. Probes, (19960000), vol. 10, pages 257 - 271-
DESCRIPTION- CACERES-CORTES, Anticancer Agents Med Chem., (20081000), vol. 8, no. 7, pages 717 - 22-
DESCRIPTION- CHAMPSAUR, M.; LANIER, L.L., "Effect of NKG2D ligand expression on host immune responses", Immunol Rev, (20100000), vol. 235, pages 267 - 285-
DESCRIPTION- CHEMICAL ABSTRACTS, Database accession no. 1056634-68-4-
DESCRIPTION- CHEMICAL ABSTRACTS, Database accession no. 111358-88-4-
DESCRIPTION- CHEMICAL ABSTRACTS, Database accession no. 1187594-09-7-
DESCRIPTION- CHEMICAL ABSTRACTS, Database accession no. 1271022-90-2-
DESCRIPTION- CHEMICAL ABSTRACTS, Database accession no. 133550-30-8-
DESCRIPTION- CHEMICAL ABSTRACTS, Database accession no. 857064- 42-7-
DESCRIPTION- CHEMICAL ABSTRACTS, Database accession no. 936091-26-8-
DESCRIPTION- CHEMICAL ABSTRACTS, Database accession no. 937272-79-2-
DESCRIPTION- CHEMICAL ABSTRACTS, Database accession no. 941678-49-5-
DESCRIPTION- CHEN et al., Proc. Natl. Acad. Sci. USA, (19940000), vol. 91, pages 3054 - 3057-
DESCRIPTION- CHENG et al., Immunol Rev., (20110500), vol. 241, no. 1, pages 63 - 76-
DESCRIPTION- CHIOSSONE, L. et al., "Molecular analysis of the methylprednisolone-mediated inhibition of NK-cell function: evidence for different susceptibility of IL-2- versus IL-15-activated NK cells", Blood, (20070000), vol. 109, pages 3767 - 3775-
DESCRIPTION- CHRISTIAN et al., J. Mol. Biol., (19920000), vol. 227, pages 711 - 718-
DESCRIPTION- CLEVELAND WL et al., J Immunol Methods, (19830000), vol. 56, no. 2, pages 221 - 234-
DESCRIPTION- CREED, T.J. et al., "The effects of cytokines on suppression of lymphocyte proliferation by dexamethasone", J Immunol, (20090000), vol. 183, pages 164 - 171-
DESCRIPTION- CURRAN, S.A.; FITZGERALD, O.M.; COSTELLO, P.J.; SELBY, J.M.; KANE, D.J.; BRESNIHAN, B.; WINCHESTER, R., "Nucleotide sequencing of psoriatic arthritis tissue before and during methotrexate administration reveals a complex inflammatory T cell infiltrate with very few clones exhibiting features that suggest they drive the inflammatory process by recognizing autoantigens", J Immunol, (20040000), vol. 172, pages 1935 - 1944-
DESCRIPTION- DALLAS et al., Med. Sci. Monit., (20060000), vol. 12, no. 4, pages RA67 - 74-
DESCRIPTION- DANDEKAR, A.A.; O'MALLEY, K.; PERLMAN, S., "Important roles for gamma interferon and NKG2D in gammadelta T-cell-induced demyelination in T-cell receptor beta-deficient mice infected with a coronavirus", J Virol, (20050000), vol. 79, pages 9388 - 9396-
DESCRIPTION- DE JONG, A.; PENA-CRUZ, V.; CHENG, T.Y.; CLARK, R.A.; VAN RHIJN, I.; MOODY, D.B., "CDla-autoreactive T cells are a normal component of the human alphabeta T cell repertoire", Nat Immunol, (20100000), vol. 11, pages 1102 - 1109-
DESCRIPTION- DELAMERE F M et al., "Interventions for alopecia areata", THE COCHRANE DATABASE OF SYSTEMATIC REVIEWS 2008, (20080000), page CD004413-
DESCRIPTION- DELAMERE FM; SLADDEN MM; DOBBINS HM; LEONARDI-BEE J, "Interventions for alopecia areata", Cochrane Database Syst Rev., (20080000), vol. 2, page 004413-
DESCRIPTION- DELAMERE, F.M.; SLADDEN, M.M.; DOBBINS, H.M.; LEONARDI-BEE, J., "Interventions for alopecia areata", Cochrane Database Syst Rev, (20080000), vol. CD004413-
DESCRIPTION- DEMIRTURK, N.; AYKIN, N.; DEMIRDAL, T.; CEVIK, F., "Alopecia universalis: a rare side effect seen on chronic hepatitis C treatment with peg-IFN and ribavirin", Eur J Dermatol, (20060000), vol. 16, pages 579 - 580-
DESCRIPTION- DEVLIN et al., Science, (19900000), vol. 249, pages 404 - 406-
DESCRIPTION- DNA Cloning: A Practical Approach, (19850000), vol. I and II-
DESCRIPTION- DURING et al., Ann. Neurol., (19890000), vol. 25, page 351-
DESCRIPTION- DU VIVIER, A.; MUNRO, D.D., "Alopecia areata, autoimmunity, and Down's syndrome", Br Med J, (19750000), vol. 1, pages 191 - 192-
DESCRIPTION- DZAU et al., Trends in Biotechnology, (19930000), vol. 11, pages 205 - 210-
DESCRIPTION- ELBASHIR et al., Nature, (20010000), vol. 411, page 494 498-
DESCRIPTION- ELIYAHU et al., Molecules, (20050131), vol. 10, no. 1, pages 34 - 64-
DESCRIPTION- ELLINGTON et al., Nature, (19920000), vol. 355, pages 850 - 852-
DESCRIPTION- ERB et al., Proc. Natl. Acad. Sci. USA, (19940000), vol. 91, pages 11422 - 11426-
DESCRIPTION- FADERL et al., Anticancer Res., (20050500), vol. 25, no. 3B, pages 1841 - 50-
DESCRIPTION- FADERL et al., Anticancer Res., vol. 25, no. 3B, pages 1841 - 50-
DESCRIPTION- FAINSOD A et al., Mech Dev, (19970000), vol. 63, pages 39 - 50-
DESCRIPTION- FIERS et al., Nature, (19730000), vol. 273, page 113-
DESCRIPTION- FODOR et al., Science, (19910000), vol. 251, pages 767 - 773-
DESCRIPTION- FOITZIK et al., American Journal of Pathology, (20060300), vol. 168, no. 3, pages 748 - 756-
DESCRIPTION- FOWLKES et al., BioTechniques, (19920000), vol. 13, pages 422 - 427-
DESCRIPTION- FREYSCHMIDT-PAUL et al., Br J Dermatol., vol. 155, no. 3, pages 515 - 521-
DESCRIPTION- FREYSCHMIDT-PAUL; K.J. MCELWEE; R. HOFFMANNL; J.P. SUNDBERG; M.VITACOLONNA; S. KISSLING; M. ZOLLER, "Interferon-gamma-deficient mice are resistant to the development of alopecia areata", Br J Dermatol., (20060000), vol. 155, no. 3, pages 515 - 21-
DESCRIPTION- FREYSCHMIDT-PAUL, P. et al., "Interferon-gamma-deficient mice are resistant to the development of alopecia areata", Br J Dermatol, (20060000), vol. 155, pages 515 - 521-
DESCRIPTION- FREYSCHMIDT-PAUL, P.; MCELWEE, K.J.; HOFFMANN, R.; SUNDBERG, J.P.; VITACOLONNA, M.; KISSLING, S.; ZOLLER, M., "Interferon-gamma-deficient mice are resistant to the development of alopecia areata", Br J Dermatol, (20060000), vol. 155, pages 515 - 521-
DESCRIPTION- FRIEDMANN, Science, (19890000), vol. 244, pages 1275 - 1281-
DESCRIPTION- GALLOP et al., J. Medicinal Chemistry, (19940000), vol. 37, no. 9, pages 1233 - 1251-
DESCRIPTION- GAMER LW et al., Dev Biol, (19990000), vol. 208, pages 222 - 32-
DESCRIPTION- "GenBank", Database accession no. AAA98760-
DESCRIPTION- "GenBank", Database accession no. ADA59516-
DESCRIPTION- "GenBank", Database accession no. NP 002218-
DESCRIPTION- "GenBank", Database accession no. NP 004963-
DESCRIPTION- GHOREISHI, M.; MARTINKA, M.; DUTZ, J.P., "Type 1 interferon signature in the scalp lesions of alopecia areata", Br J Dermatol.-
DESCRIPTION- GILHAR, A. et al., "Transfer of alopecia areata in the human scalp graft/Prkdc(scid) (SCID) mouse system is characterized by a TH1 response", Clin Immunol, (20030000), vol. 106, pages 181 - 187-
DESCRIPTION- GILHAR A.; KAM Y.; ASSY B.; KALISH R., "Alopecia areata induced in C3H/HeJ mice by interferon-gamma: evidence for loss of immune privilege", Journal Invest. Dermatol., (20050000), vol. 124, no. l, pages 288 - 9-
DESCRIPTION- GILHAR, A.; KAM, Y.; ASSY, B.; KALISH, R.S., "Alopecia areata induced in C3H/HeJ mice by interferon-gamma: evidence for loss of immune privilege", J Invest Dermatol, (20050000), vol. 124, pages 288 - 289-
DESCRIPTION- GILHAR A; LANDAU M; ASSY B et al., "Transfer of alopecia areata in the human scalp graft/Prkdc(scid) (SCID) mouse system is characterized by a TH1 response", Clin Immunol, (20030000), vol. 106, pages 181 - 7-
DESCRIPTION- GILHAR, A.; PAUS, R.; KALISH, R.S., "Lymphocytes, neuropeptides, and genes involved in alopecia areata", J Clin Invest, (20070000), vol. 117, pages 2019 - 2027-
DESCRIPTION- GILHAR A; SHALAGINOV R; ASSY B; SERAFIMOVICH S; KALISH RS, "Alopecia areata is a T-lymphocyte mediated autoimmune disease: lesional human T-lymphocytes transfer alopecia areata to human skin grafts on SCID mice", J Investig Dermatol Symp Proc, (19990000), vol. 4, pages 207 - 10-
DESCRIPTION- GILHAR et al., Journal Invest. Dermatol., vol. 124, no. l, pages 288 - 289-
DESCRIPTION- GOEDDEL, Gene Expression Technology: Methods in Enzymology, Academic Press, (19900000), vol. 185-
DESCRIPTION- GOH, C.; FINKEL, M.; CHRISTOS, P.J.; SINHA, A.A., "Profile of 513 patients with alopecia areata: associations of disease subtypes with atopy, autoimmune disease and positive family history", J Eur Acad Dermatol Venereol, (20060000), vol. 20, pages 1055 - 1060-
DESCRIPTION- GOLEVA, E.; KISICH, K.O.; LEUNG, D.Y., "A role for STAT5 in the pathogenesis of IL-2-induced glucocorticoid resistance", J Immunol, (20020000), vol. 169, pages 5934 - 5940-
DESCRIPTION- GOODSON, Medical Applications of Controlled Release, (19840000), vol. 2, pages 115 - 138-
DESCRIPTION- GREGORIOU, S. et al., "Cytokines and other mediators in alopecia areata", Mediators Inflamm, (20100000), vol. 928030-
DESCRIPTION- GUATELLI, Proc. Natl. Acad. Sci. USA, (19900000), vol. 87, page 1874-
DESCRIPTION- HAGER GL et al., Curr Opin Genet Dev, (20020000), vol. 12, no. 2, pages 137 - 41-
DESCRIPTION- HENSEN, Curr Med Chem, (20060000), vol. 13, no. 4, pages 361 - 76-
DESCRIPTION- HERWEIJER et al., Gene Ther., (20070100), vol. 14, no. 2, pages 99 - 107-
DESCRIPTION- HIMPE et al., Biofactors, (20090100), vol. 35, no. 1, pages 76 - 81-
DESCRIPTION- HIROTA, R. et al., "Induction of hair regrowth in the alopecia site of IFN-gamma knockout mice by allografting and IFN-gamma injection into the transplantation site", J Interferon Cytokine Res, (20030000), vol. 23, pages 433 - 439-
DESCRIPTION- HIROTA, R.; TAJIMA, S.; YONEDA, Y.; OKADA, M.; TASHIRO, J.; UEDA, K.; KUBOTA, T.; YOSHIDA, R., "Induction of hair regrowth in the alopecia site of IFN-gamma knockout mice by allografting and IFN-gamma injection into the transplantation site", J Interferon Cytokine Res, (20030000), vol. 23, pages 433 - 439-
DESCRIPTION- HOFFMAN, A. S., Adv Drug Deliv Rev., (20020000), vol. 43, pages 3 - 12-
DESCRIPTION- HOFFMAN, A. S., Ann NY Acad Sci, (20010000), vol. 944, pages 62 - 73-
DESCRIPTION- HOFFMANN, R. et al., "Cytokine mRNA levels in Alopecia areata before and after treatment with the contact allergen diphenylcyclopropenone", J Invest Dermatol, (19940000), vol. 103, pages 530 - 533-
DESCRIPTION- HOUGHTEN et al., Biotechniques, (19920000), vol. 13, page 412-
DESCRIPTION- HOUGHTEN et al., Nature, (19910000), vol. 354, pages 84 - 86-
DESCRIPTION- HOWARD et al., J. Neurosurg., (19890000), vol. 71, page 105-
DESCRIPTION- HUDSON, Curr. Opin. Biotechnol., (19980000), vol. 9, pages 395 - 402-
DESCRIPTION- HU, J.K.; KAGARI, T.; CLINGAN, J.M.; MATLOUBIAN, M., "Expression of chemokine receptor CXCR3 on T cells affects the balance between effector and memory CD8 T-cell generation", Proc Natl Acad Sci USA, vol. 108, pages El 18 - 127-
DESCRIPTION- IEMURA S et al., PNAS, (19980000), vol. 77, pages 649 - 52-
DESCRIPTION- ISAKA et al., Expert Opin Drug Deliv., (20070900), vol. 4, no. 5, pages 561 - 71-
DESCRIPTION- ITO, T. et al., "Collapse and restoration of MHC class-I-dependent immune privilege: exploiting the human hair follicle as a model", Am JPathol, (20040000), vol. 164, pages 623 - 634-
DESCRIPTION- ITO T; MEYER KC; ITO N; PAUS R, "Immune privilege and the skin", Curr Dir Autoimmun, (20080000), vol. 10, pages 27 - 52-
DESCRIPTION- ITO, T.; MEYER, K.C.; ITO, N.; PAUS, R., "Immune privilege and the skin", Curr Dir Autoimmun, (20080000), vol. 10, pages 27 - 52-
DESCRIPTION- IVANENKOV et al., Mini Rev Med Chem., (20110100), vol. l 1, no. 1, pages 55 - 78-
DESCRIPTION- IVANENKOV et al., Mini Rev Med Chem., (20110100), vol. ll, no. l, pages 55 - 78-
DESCRIPTION- JACKOW C; PUFFER N; HORDINSKY M; NELSON J; TARRAND J; DUVIC M, "Alopecia areata and cytomegalovirus infection in twins: genes versus environment?", J Am Acad Dermatol, (19980000), vol. 38, pages 418 - 25-
DESCRIPTION- JAGER et al., Curr Gene Ther., (20070800), vol. 7, no. 4, pages 272 - 83-
DESCRIPTION- JAYAWICKREME et al., Proc. Natl. Acad. Sci. USA, (19940000), vol. 91, pages 1614 - 1618-
DESCRIPTION- JELINEK JE, "Sudden whitening of the hair", Bull N Y Acad Med, (19720000), vol. 48, pages 1003 - 13-
DESCRIPTION- JENSEN et al., Ann Med., (20070000), vol. 39, no. 2, pages 108 - 15-
DESCRIPTION- JONES et al., Hum Genet., (20000000), vol. 106, no. 6, pages 663 - 8-
DESCRIPTION- KALOTA et al., Handb. Exp. Pharmacol., (20060000), vol. 173, pages 173 - 96-
DESCRIPTION- KARAMAN, M.W. et al., "A quantitative analysis of kinase inhibitor selectivity", Nat Biotechnol, (20080000), vol. 26, pages 127 - 132-
DESCRIPTION- KARTAL, E.D.; ALPAT, S.N.; OZGUNES, I.; USLUER, G., "Adverse effects of high-dose interferon-alpha-2a treatment for chronic hepatitis B", Adv Ther, (20070000), vol. 24, pages 963 - 971-
DESCRIPTION- KARTAL, E.D.; ALPAT, S.N.; OZGUNES, I.; USLUER, G., "Reversible alopecia universalis secondary to PEG-interferon alpha-2b and ribavirin combination therapy in a patient with chronic hepatitis C virus infection", Eur J Gastroenterol Hepatol, (20070000), vol. 19, pages 817 - 820-
DESCRIPTION- KASUMAGIC-HALILOVIC, E., "Thyroid autoimmunity in patients with alopecia areata", Acta Dermatovenerol Croat, (20080000), vol. 16, pages 123 - 125-
DESCRIPTION- KAY et al., Gene, (19930000), vol. 128, pages 59 - 65-
DESCRIPTION- KENNETH J. SHEA, "Molecular Imprinting of Synthetic Network Polymers: The De Novo synthesis of Macromolecular Binding and Catalytic Sites", TRIP, (19940500), vol. 2, no. 5, XP002082395-
DESCRIPTION- KERNLAND, K.H.; HUNZIKER, T., "Alopecia areata induced by interferon alpha?", Dermatology, (19990000), vol. 198, pages 418 - 419-
DESCRIPTION- KIKUCHI et al., J Dermatol Sci., (20080500), vol. 50, no. 2, pages 87 - 98-
DESCRIPTION- KILLOCK, D., "Experimental arthritis: NKG2D: a potential therapeutic target in RA?", Nat Rev Rheumatol, (20110000), vol. 7, page 438-
DESCRIPTION- KOHLMEIER, J.E. et al., "Inflammatory chemokine receptors regulate CD8(+) T cell contraction and memory generation following infection", J Exp Med, vol. 208, pages 1621 - 1634-
DESCRIPTION- KONDO, S.; HOZUMI, Y.; ASO, K., "Organ culture of human scalp hair follicles: effect of testosterone and oestrogen on hair growth.", Arch Dermatol Res, (19900000), vol. 282, pages 442 - 445-
DESCRIPTION- KORHONEN et al., Basic Clin Pharmacol Toxicol., (20090400), vol. 104, no. 4, pages 276 - 84-
DESCRIPTION- KURACHI, M. et al., "Chemokine receptor CXCR3 facilitates CD8(+) T cell differentiation into short-lived effector cells leading to memory degeneration", JExp Med, vol. 208, pages 1605 - 1620-
DESCRIPTION- KUWANO, Y. et al., "Serum chemokine profiles in patients with alopecia areata", Br J Dermatol, (20070000), vol. 157, pages 466 - 473-
DESCRIPTION- KWOH, Proc. Natl. Acad. Sci. USA, (19890000), vol. 86, page 1173-
DESCRIPTION- KYRIAKIS KP; PALTATZIDOU K; KOSMA E; SOFOURI E; TADROS A; RACHIOTI E, "Alopecia areata prevalence by gender and age", J Eur Acad Dermatol Venereol., (20090000), vol. 23, pages 572 - 3-
DESCRIPTION- LAM et al., Nature, (19910000), vol. 354, pages 82 - 84-
DESCRIPTION- LANDEGREN, Science, (19880000), vol. 241, page 1077-
DESCRIPTION- LANG, A.M.; NORLAND, A.M.; SCHUNEMAN, R.L.; TOPE, W.D., "Localized interferon alfa-2b-induced alopecia", Arch Dermatol, (19990000), vol. 135, pages 1126 - 1128-
DESCRIPTION- LANGER, Science, (19900000), vol. 249, pages 1527 - 1533-
DESCRIPTION- LANIER, Nat Immunol., (20080500), vol. 9, no. 5, pages 495 - 502-
DESCRIPTION- LEE et al., Biomaterials, (20040000), vol. 25, pages 2461 - 2466-
DESCRIPTION- LENSTRA, J. Immunol. Meth., (19920000), vol. 152, pages 149 - 157-
DESCRIPTION- LEVY et al., Science, (19850000), vol. 228, page 190-
DESCRIPTION- LOWELL, Cold Spring Harb Perspect Biol., (20110301), vol. 3, no. 3, page a002352-
DESCRIPTION- LUTZELBURGER et al., Handb. Exp. Pharmacol., (20060000), vol. 173, pages 243 - 59-
DESCRIPTION- MALEK; CASTRO, Immunity, (20100827), vol. 33, no. 2, pages 153 - 65-
DESCRIPTION- MALKINSON FD; JT KEARN, Int J Dermatol, (19780000), vol. 17, pages 536 - 551-
DESCRIPTION- MANNHOLD, Curr Top Med Chem, (20060000), vol. 6, no. 10, pages 1031 - 47-
DESCRIPTION- MATICIC, M.; POLJAK, M.; LUNDER, T.; RENER-SITAR, K.; STOJANOVIC, L., "Lichen planus and other cutaneous manifestations in chronic hepatitis C: pre- and post-interferon-based treatment prevalence vary in a cohort of patients from low hepatitis C virus endemic area", J Eur Acad Dermatol Venereol, (20080000), vol. 22, pages 779 - 788-
DESCRIPTION- MATTHEAKIS et al., Proc. Natl. Acad. Sci. USA, (19940000), vol. 91, pages 9022 - 9026-
DESCRIPTION- MAYNARD et al., Ann. Rev. Biomed. Eng., (20000000), vol. 2, pages 339 - 76-
DESCRIPTION- MCCONNELL et al., Science, (19920000), vol. 257, pages 1906 - 1912-
DESCRIPTION- MCDONAGH AJ; TAZI-AHNINI R, "Epidemiology and genetics of alopecia areata", Clin Exp Dermatol, (20020000), vol. 27, pages 405 - 9-
DESCRIPTION- MCELWEE, K.; BOGGESS, D.; MILLER, J.; KING, L.; SUNDBERG, J., "Spontaneous alopecia areata-like hair loss in one congenic and seven inbred laboratory mouse strains", J Invest Dermatol Symp Proc, (19990000), vol. 4, pages 202 - 206-
DESCRIPTION- MCELWEE, K.J. et al., "Transfer of CD8(+) cells induces localized hair loss whereas CD4(+)/CD25(-) cells promote systemic alopecia areata and CD4(+)/CD25(+) cells blockade disease onset in the C3H/HeJ mouse model", J Invest Dermatol, (20050000), vol. 124, pages 947 - 957-
DESCRIPTION- MCELWEE KJ; FREYSCHMIDT-PAUL P; HOFFMANN R et al., "Transfer of CD8(+) cells induces localized hair loss whereas CD4(+)/CD25(-) cells promote systemic alopecia areata and CD4(+)/CD25(+) cells blockade disease onset in the C3H/HeJ mouse model", The Journal of investigative dermatology, (20050000), vol. 124, pages 947 - 57-
DESCRIPTION- MCMNAUS; SHARP, Nat Rev Genetics, (20020000), vol. 3, pages 737 - 47-
DESCRIPTION- MEDYNSKI, BioTechnology, (19940000), vol. 12, pages 709 - 710-
DESCRIPTION- MERESSE, B.; CURRAN, S.A.; CISZEWSKI, C.; ORBELYAN, G.; SETTY, M.; BHAGAT, G.; LEE, L.; TRETIAKOVA, M.; SEMRAD, C.; KISTNER, E. et, "Reprogramming of CTLs into natural killer-like cells in celiac disease", J Exp Med, (20060000), vol. 203, pages 1343 - 1355-
DESCRIPTION- MERESSE, B et al, "Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease", Immunity, (20040000), vol. 21, pages 357 - 366-
DESCRIPTION- MILLER, Nature, (19920000), vol. 357, pages 455 - 460-
DESCRIPTION- MISTRY, N.; SHAPERO, J.; CRAWFORD, R.I., "A review of adverse cutaneous drug reactions resulting from the use of interferon and ribavirin", Can J Gastroenterol, (20090000), vol. 23, pages 677 - 683-
DESCRIPTION- MOCSAI et al., Nat Rev Immunol., (20100600), vol. 10, no. 6, pages 387 - 402-
DESCRIPTION- Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory, (20010000), vol. 1-3-
DESCRIPTION- MOSBACH, Trends in Biochem. Sci., (19940000), vol. 19, no. 9-
DESCRIPTION- MOURICH; IVERSON, "Splicing in the immune system: Potential targets for therapeutic intervention by antisense-mediated alternative splicing", Curr. Opinion Mol. Ther., (20090000), vol. 11, no. 2, pages 124 - 132-
DESCRIPTION- NAKAMURA et al., Am J Pathol, (20080000), vol. 172, no. 3, pages 650 - 658-
DESCRIPTION- NAKAMURA et al., "Controlled Delivery of T-box21 Small Interfering RNA Ameliorates Autoimmune Alopecia (Alopecia Areata) in a C3H/HeJ Mouse Model", Am JPathol., (20080000), vol. 172, no. 3, pages 650 - 658-
DESCRIPTION- NAKAMURA M et al., FASEB J, (20030000), vol. 17, no. 3, pages 497 - 9-
DESCRIPTION- NAKAMURA, M.; JO, J.; TABATA, Y.; ISHIKAWA, O., "Controlled delivery of T-box21 small interfering RNA ameliorates autoimmune alopecia (Alopecia Areata) in a C3H/HeJ mouse model", Am JPathol, (20080000), vol. 172, pages 650 - 658-
DESCRIPTION- NAKAMURA T et al., Nature, (19900000), vol. 247, pages 836 - 8-
DESCRIPTION- NUCKEL, H. et al., "The prognostic significance of soluble NKG2D ligands in B-cell chronic lymphocytic leukemia", Leukemia, (20100000), vol. 24, pages 1152 - 1159-
DESCRIPTION- OGASAWARA, K.; HAMERMAN, J.A.; EHRLICH, L.R.; BOUR-JORDAN, H.; SANTAMARIA, P.; BLUESTONE, J.A.; LANIER, L.L., "NKG2D blockade prevents autoimmune diabetes in NOD mice", Immunity, (20040000), vol. 20, pages 757 - 767-
DESCRIPTION- OHLMEYER et al., Proc. Natl. Acad. Sci. USA, (19930000), vol. 90, pages 10922 - 10926-
DESCRIPTION- OLDENBURG et al., Proc. Natl. Acad. Sci. USA, (19920000), vol. 89, pages 5393 - 5397-
DESCRIPTION- OLIVER RF; CA JAHODA et al., Biology of Wool and Hair, University Press, (19710000), pages 51 - 67-
DESCRIPTION- OLIVER RF, J Soc Cosmet Chem, (19710000), vol. 22, pages 741 - 755-
DESCRIPTION- OSTRESH et al., Proc. Natl. Acad. Sci. USA, (19940000), vol. 91, pages 11138 - 11142-
DESCRIPTION- PARDANANI et al., J Clin Oncol., (20110301), vol. 29, no. 7, pages 789 - 96-
DESCRIPTION- PARDANANI et al., Leukemia, (20090800), vol. 23, no. 8, pages 1441 - 5-
DESCRIPTION- PARMLEY; SMITH, Adv. Exp. Med. Biol., (19890000), vol. 251, pages 215 - 218-
DESCRIPTION- PATEL K, Intl JBiochem Cell Bio, (19980000), vol. 30, pages 1087 - 93-
DESCRIPTION- PAUS, R.; ITO, N.; TAKIGAWA, M.; ITO, T., "The hair follicle and immune privilege", J Investig Dermatol Symp Proc, (20030000), vol. 8, pages 188 - 194-
DESCRIPTION- PAUS, R.; SLOMINSKI, A.; CZARNETZKI, B.M., "Is alopecia areata an autoimmune-response against melanogenesis-related proteins, exposed by abnormal MHC class I expression in the anagen hair bulb?", Yale J Biol Med, (19930000), vol. 66, pages 541 - 554-
DESCRIPTION- PEPPAS et al., Adv Mater., (20060000), vol. 18, pages 1345 - 60-
DESCRIPTION- PETHUKOVA et al., Nature, (20100000), vol. 466, no. 7302, pages 1 13 - 7-
DESCRIPTION- PHILPOTT, M.P.; SANDERS, D.A.; KEALEY, T., "Whole hair follicle culture", Dermatol Clin, (19960000), vol. 14, pages 595 - 607-
DESCRIPTION- POSADAS et al., Expert Rev Clin Immunol., (20090100), vol. 5, no. l, pages 9 - 17-
DESCRIPTION- PUAVILAI, S.; PUAVILAI, G.; CHARUWICHITRATANA, S.; SAKUNTABHAI, A.; SRIPRACHYA-ANUNT, S., "Prevalence of thyroid diseases in patients with alopecia areata", Int J Dermatol, (19940000), vol. 33, pages 632 - 633-
DESCRIPTION- RADNY, P. et al., "Alopecia areata induced by adjuvant treatment with alpha-interferon in malignant melanoma?", Dermatology, (20040000), vol. 209, pages 249 - 250-
DESCRIPTION- RAMSBORG, C.G.; PAPOUTSAKIS, E.T., "Global transcriptional analysis delineates the differential inflammatory response interleukin-15 elicits from cultured human T cells", Exp Hematol, (20070000), vol. 35, pages 454 - 464-
DESCRIPTION- RANGER; PEPPAS, J. Macromol. Sci. Rev. Macromol. Chem., (19830000), vol. 23, page 61-
DESCRIPTION- REBAR et al., Science, (19930000), vol. 263, pages 671 - 673-
DESCRIPTION- RENTZOS, M. et al., "Circulating interleukin-15 and RANTES chemokine in MS patients: effect of treatment with methylprednisolone in patients with relapse", Neurol Res, (20090000), vol. 32, pages 684 - 689-
DESCRIPTION- REYNOLDS AJ; CA JAHODA, Development, (19920000), vol. 115, pages 587 - 593-
DESCRIPTION- REYNOLDS AJ et al., J Invest Dermatol, (19930000), vol. 101, pages 634 - 38-
DESCRIPTION- SAFAVI, K.H.; MULLER, S.A.; SUMAN, V.J.; MOSHELL, A.N.; MELTON, L.J., "3rd Incidence of alopecia areata in Olmsted County, Minnesota, 1975 through 1989", Mayo Clin Proc, (19950000), vol. 70, pages 628 - 633-
DESCRIPTION- SAFAVI KH; MULLER SA; SUMAN VJ; MOSHELL AN; MELTON LJ, "Incidence of alopecia areata in Olmsted County, Minnesota, 1975 through 1989", Mayo Clin Proc, (19950000), vol. 70, pages 628 - 33-
DESCRIPTION- SALMON et al., Proc. Natl. Acad. Sci. USA, (19930000), vol. 90, pages 11708 - 11712-
DESCRIPTION- SAUDEK et al., N. Engl. J. Med., (19890000), vol. 321, page 574-
DESCRIPTION- SCOTT et al., Science, (19900000), vol. 249, pages 386 - 390-
DESCRIPTION- SCOTT; SMITH, Science, (19900000), vol. 249, pages 386 - 390-
DESCRIPTION- SEFTON, CRC Crit. Ref. Biomed. Eng., (19870000), vol. 14, page 201-
DESCRIPTION- SEN; BLAU, FASEB J., (20060000), vol. 20, pages 1293 - 99-
DESCRIPTION- SIMON et al., Proc. Natl. Acad. Sci. USA, (19920000), vol. 89, pages 9367 - 9371-
DESCRIPTION- SJOLANDER, URBANICZKY, Anal. Chem., (19910000), vol. 63, pages 2338 - 2345-
DESCRIPTION- SKURKOVICH, S.; KOROTKY, N.G.; SHAROVA, N.M.; SKURKOVICH, B., "Treatment of alopecia areata with anti-interferon-gamma antibodies", J Investig Dermatol Symp Proc, (20050000), vol. 10, pages 283 - 284-
DESCRIPTION- SKURKOVICH, S.; KOROTKY, N.G.; SHAROVA, N.M.; SKURKOVICH, B., "Treatment of alopecia areata with anti-interferon-gamma antibodies", JInvestig Dermatol Symp Proc, (20050000), vol. 10, pages 283 - 284-
DESCRIPTION- SMITH, J. Clin. Microbiol., (19970000), vol. 35, pages 1477 - 1491-
DESCRIPTION- SOOKNANAN, Biotechnology, (19950000), vol. 13, pages 563 - 564-
DESCRIPTION- STAUDT et al., Science, (19880000), vol. 241, pages 577 - 580-
DESCRIPTION- STROBER, B.E. et al., "Alefacept for severe alopecia areata: a randomized, double-blind, placebo-controlled study", Arch Dermatol, (20090000), vol. 145, pages 1262 - 1266-
DESCRIPTION- SUBRAMANYA, R.D.; CODA, A.B.; SINHA, A.A., "Transcriptional profiling in alopecia areata defines immune and cell cycle control related genes within disease-specific signatures", Genomics, (20100000), vol. 96, pages 146 - 153, XP027213273-
DESCRIPTION- SUNDBERG, B.A.; SCHOFIELD, P.N.; GRUENBERGER, M.; SUNDBERG, J.P., "A data capture tool for mouse pathology phenotyping", Vet Pathol, (20090000), vol. 46, pages 1230 - 1240-
DESCRIPTION- SUNDBERG, J.P.; BOGGESS, D.; MONTAGUTELLI, X.; HOGAN, M.E.; KING, L.E., JR., "C3H/HeJ mouse model for alopecia areata", J Invest Dermatol, (19950000), vol. 104, pages 16S - 17S-
DESCRIPTION- SUNDBERG, J.P.; OLIVER, R.F.; MCELWEE, K.J.; KING, L.E., JR., "Alopecia areata in humans and other mammalian species", J Invest Dermatol, (19950000), vol. 104, pages 32S - 33S-
DESCRIPTION- SUNDBERG, J.P.; SILVA, K.A.; MCPHEE, C.; KING, L.E., "Skin diseases in laboratory mice: approaches to drug target identification and efficacy screening", Methods Mol Biol, (20100000), vol. 602, pages 193 - 213-
DESCRIPTION- SUNDBERG, J.P.; SUNDBERG, B.A.; SCHOFIELD, P.N., "Integrating mouse anatomy and pathology ontologies into a diagnostic/phenotyping database: tools for record keeping and teaching", Mammalian Genome, (20080000), vol. 19, pages 413 - 419-
DESCRIPTION- SUN, J.; SILVA, K.A.; MCELWEE, K.J.; KING, L.E., JR.; SUNDBERG, J.P., "The C3H/HeJ mouse and DEBR rat models for alopecia areata: review of preclinical drug screening approaches and results", Exp Dermatol, (20080000), vol. 17, pages 793 - 805-
DESCRIPTION- SUN, J.; SILVA, K.A.; MCELWEE, K.J.; KING, L.E.; SUNDBERG, J.P., "The C3H/HeJ mouse and DEBR rat models for alopecia areata: preclinical drug screening tools", Exp Dermatol, (20080000), vol. 17, pages 793 - 805-
DESCRIPTION- SZABO et al., Curr. Opin. Struct. Biol., (19950000), vol. 5, pages 699 - 705-
DESCRIPTION- TALIANI, G. et al., "Reversible alopecia universalis during treatment with PEG-interferon and ribavirin for chronic hepatitis", C. J Chemother, (20050000), vol. 17, pages 212 - 214-
DESCRIPTION- TLIBA, O. et al., "Cytokines induce an early steroid resistance in airway smooth muscle cells: novel role of interferon regulatory factor-1", Am JRespir Cell Mol Biol, (20080000), vol. 38, pages 463 - 472-
DESCRIPTION- TUERK et al., Proc. Natl. Acad. Sci. USA, (19920000), vol. 89, pages 6988 - 6992-
DESCRIPTION- UENO N et al., PNAS, (19870000), vol. 84, pages 8282 - 86-
DESCRIPTION- UNDERHILL CB, J Invest Dermatol, (19930000), vol. 101, no. 6, pages 820 - 6-
DESCRIPTION- VAN DER STEEN P; TRAUPE H; HAPPLE R; BOEZEMAN J; STRATER R; HAMM H, "The genetic risk for alopecia areata in first degree relatives of severely affected patients. An estimate", Acta Derm Venereol, (19920000), vol. 72, pages 373 - 5-
DESCRIPTION- VERMA, Scientific American, (19900000), vol. 68-84-
DESCRIPTION- VERSTOVSEK, S. et al., "Safety and efficacy of INCB018424, a JAK1 and JAK2 inhibitor, in myelofibrosis", NEngl J Med, (20100000), vol. 363, pages 1117 - 1127-
DESCRIPTION- VITAL et al., Ther Clin Risk Manag., (20061200), vol. 2, no. 4, pages 365 - 75-
DESCRIPTION- WAEHLER et al., Nat Rev Genet., (20070800), vol. 8, no. 8, pages 573 - 87-
DESCRIPTION- WANG et al., Curr Med Chem, (20070000), vol. 14, no. 2, pages 133 - 55-
DESCRIPTION- WANG, S.J.; SHOHAT, T.; VADHEIM, C.; SHELLOW, W.; EDWARDS, J.; ROTTER, J.I., "Increased risk for type I (insulin-dependent) diabetes in relatives of patients with alopecia areata (AA", Am J Med Genet, (19940000), vol. 51, pages 234 - 239-
DESCRIPTION- WASSERMAN, D.; GUZMAN-SANCHEZ, D.A.; SCOTT, K.; MCMICHAEL, A., "Alopecia areata", Int J Dermatol, (20070000), vol. 46, pages 121 - 131-
DESCRIPTION- WERNER et al., Brief Funct. Genomic Proteomic, (20060000), vol. 5, no. l, pages 32 - 6-
DESCRIPTION- WERNIG et al., Cancer Cell., (20080400), vol. 13, no. 4, pages 311 - 20-
DESCRIPTION- WILLIAM et al., J Med Chem., (20110714), vol. 54, no. 13, pages 4638 - 58-
DESCRIPTION- WU, Genomics, (19890000), vol. 4, page 560-
DESCRIPTION- WU, H.D.; MAURER, M.S.; FRIEDMAN, R.A.; MARBOE, C.C.; RUIZ-VAZQUEZ, E.M.; RAMAKRISHNAN, R.; SCHWARTZ, A.; TILSON, M.D.; STEWART, A, "The lymphocytic infiltration in calcific aortic stenosis predominantly consists of clonally expanded T cells", J Immunol, (20070000), vol. 178, pages 5329 - 5339-
DESCRIPTION- WULFF, G., Polymeric Reagents and Catalysts, American Chemical Society, (19860000), pages 186 - 230-
DESCRIPTION- XU, Q.; GOLEVA, E.; OU, L.S.; LI, L.B.; LEUNG, D.Y., "CD56+ cells induce steroid resistance in B cells exposed to IL-15", J Immunol, (20040000), vol. 172, pages 7110 - 7115-
DESCRIPTION- YANO, S.; IHN, H.; NAKAMURA, K.; OKOCHI, H.; TAMAKI, K., "Antinuclear and antithyroid antibodies in 68 Japanese patients with alopecia areata", Dermatology, (19990000), vol. 199, page 191-
DESCRIPTION- YOU et al., Ann N Y Acad Sci., (20081200), vol. l 150, pages 300 - 10-
DESCRIPTION- YU et al., Cell, (19940000), vol. 76, pages 933 - 945-
DESCRIPTION- YU, M.L. et al., "A randomised study of peginterferon and ribavirin for 16 versus 24 weeks in patients with genotype 2 chronic hepatitis C", Gut, (20070000), vol. 56, pages 553 - 559-
DESCRIPTION- ZOLLER M; MCELWEE KJ; ENGEL P; HOFFMANN R, "Transient CD44 variant isoform expression and reduction in CD4(+)/CD25(+) regulatory T cells in C3H/HeJ mice with alopecia areata", The Journal of investigative dermatology, (20020000), vol. 118, pages 983 - 92-
DESCRIPTION- COMPANJEN, A.R.; VAN DER WEL, L.I.; WEI, L.; LAMAN, J.D.; PRENS, E.P., "A modified ex vivo skin organ culture system for functional studies", Arch Dermatol Res, (20010000), vol. 293, pages 184 - 190, XP002405781
DESCRIPTION- WONG et al., "Inhibitors of the tyrosine kinase signaling cascade for asthma", Curr. Opin. Pharmacol., (20050000), vol. 5, no. 3, doi:doi:10.1016/j.coph.2005.01.009, pages 264 - 71, XP004901927
DESCRIPTION- CAILLAT-ZUCMAN, S., "How NKG2D ligands trigger autoimmunity?", Hum Immunol, (20060000), vol. 67, pages 204 - 207, XP024993277
DESCRIPTION- PAUS, R.; NICKOLOFF, B.J.; ITO, T., "A 'hairy' privilege", Trends Immunol, (20050000), vol. 26, pages 32 - 40, XP004698880
DESCRIPTION- KAELIN, U.; HASSAN, A.S.; BRAATHEN, L.R.; YAWALKAR, N., "Treatment of alopecia areata partim universalis with efalizumab", JAm Acad Dermatol, (20060000), vol. 55, pages 529 - 532, XP005603441
DESCRIPTION- BISSONNETTE, R. et al., "A randomized, double-blind, placebo-controlled, phase I study of MEDI-545, an anti-interferon-alfa monoclonal antibody, in subjects with chronic psoriasis", JAm Acad Dermatol, vol. 62, pages 427 - 436, XP026914293
DESCRIPTION- VAN BELLE, T.L.; HERRATH, M.G., "The role of the activating receptor NKG2D in autoimmunity", Molecular Immunology, (20090000), vol. 47, pages 8 - 11, XP026732963
DESCRIPTION- VAN BELLE, T.L.; HERRATH, M.G., "The role of the activating receptor NKG2D in autoimmunity", Mol Immunol, (20090000), vol. 47, pages 8 - 11, XP026732963
DESCRIPTION- TODES-TAYLOR N; TURNER R; WOOD GS; STRATTE PT; MORHENN VB, "T cell subpopulations in alopecia areata", J Am Acad Dermatol, (19840000), vol. 11, doi:doi:10.1016/S0190-9622(84)70152-6, pages 216 - 23, XP024160937
DESCRIPTION- FRIDMAN, J.S. et al., "Preclinical evaluation of local JAK1 and JAK2 inhibition in cutaneous inflammation", J Invest Dermatol, (20110000), vol. 131, pages 1838 - 1844, XP055146781
DESCRIPTION- PETUKHOVA, L. et al., "Genome-wide association study in alopecia areata implicates both innate and adaptive immunity", Nature, (20100000), vol. 466, doi:doi:10.1038/nature09114, pages 113 - 117, XP002736853
DESCRIPTION- MCKINNEY, E.F et al, "A CD8+ T cell transcription signature predicts prognosis in autoimmune disease", Nat Med, (20100000), vol. 16, pages 586 - 591, XP055419533
DESCRIPTION- CLARK, R.A.; CHONG, B.F.; MIRCHANDANI, N.; YAMANAKA, K.; MURPHY, G.F.; DOWGIERT, R.K.; KUPPER, T.S., "A novel method for the isolation of skin resident T cells from normal and diseased human skin", J Invest Dermatol, (20060000), vol. 126, pages 1059 - 1070, XP055560826
DESCRIPTION- CLARK, R.A. et al., "A novel method for the isolation of skin resident T cells from normal and diseased human skin", J Invest Dermatol, (20060000), vol. 126, pages 1059 - 1070, XP055560826
DESCRIPTION- ITO, T. et al., "Maintenance of hair follicle immune privilege is linked to prevention of NK cell attack", J Invest Dermatol, (20080000), vol. 128, pages 1196 - 1206, XP002736854
DESCRIPTION- ITO T; ITO N; SAATOFF M et al., "Maintenance of hair follicle immune privilege is linked to prevention of NK cell attack", The Journal of investigative dermatology, (20080000), vol. 128, pages 1196 - 206, XP002736854
DESCRIPTION- MAHE et al., "Androgenetic alopecia and microinflammation", International Journal of Dermatology, (20000000), vol. 39, pages 576 - 584, XP055096339
DESCRIPTION- JIN et al., "Variant of TYR and Autoimmunity Susceptibility Loci in Generalized Vitiligo", NEJM, (20100000), vol. 362, pages 1686 - 1697, XP055136390
DESCRIPTION- GROH, V.; BRUHL, A.; EL-GABALAWY, H.; NELSON, J.L.; SPIES, T., "Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis", Proc Natl Acad Sci USA, (20030000), vol. 100, pages 9452 - 9457, XP002610085
DESCRIPTION- MARTINEZ-MIR A; ZLOTOGORSKI A; GORDON D et al., "Genomewide scan for linkage reveals evidence of several susceptibility loci for alopecia areata", Am J Hum Genet, (20070000), vol. 80, pages 316 - 28, XP002490296
DESCRIPTION- SUNDBERG, J.P.; CORDY, W.R.; KING, L.E., "Alopecia areata in aging C3H/HeJ mice", J Invest Dermatol, (19940000), vol. 102, pages 847 - 856, XP055173875
DESCRIPTION- SUNDBERG, J.P.; CORDY, W.R.; KING, L.E., JR., "Alopecia areata in aging C3H/HeJ mice", J Invest Dermatol, (19940000), vol. 102, pages 847 - 856, XP055173875
DESCRIPTION- HOMMES, D.W. et al., "Fontolizumab, a humanised anti-interferon gamma antibody, demonstrates safety and clinical activity in patients with moderate to severe Crohn's disease", Gut, (20060000), vol. 55, pages 1131 - 1137, XP055056495
DESCRIPTION- SEYRAFI, H.; AKHIANI, M.; ABBASI, H.; MIRPOUR, S.; GHOLAMREZANEZHAD, A., "Evaluation of the profile of alopecia areata and the prevalence of thyroid function test abnormalities and serum autoantibodies in Iranian patients", BMC Dermatol, (20050000), vol. 5, page 11, XP021005857
DESCRIPTION- WINCHESTER, R et al, "Circulating activated and effector memory T cells are associated with calcification and clonal expansions in bicuspid and tricuspid valves of calcific aortic stenosis", J Immunol, (20110000), vol. 187, pages 1006 - 1014, XP055303430
DESCRIPTION- CLARK, R.A.; CHONG, B.; MIRCHANDANI, N.; BRINSTER, N.K.; YAMANAKA, K.; DOWGIERT, R.K.; KUPPER, T.S., "The vast majority of CLA+ T cells are resident in normal skin", J Immunol, (20060000), vol. 176, pages 4431 - 4439, XP055233494
DESCRIPTION- CLARK, R.A. et al., "The vast majority of CLA+ T cells are resident in normal skin", J Immunol, (20060000), vol. 176, doi:doi:10.4049/jimmunol.176.7.4431, pages 4431 - 4439, XP055233494
EXAMINATION- HAREL SIVAN ET AL, "Pharmacologic inhibition of JAK-STAT signaling promotes hair growth.", SCIENCE ADVANCES OCT 2015, (201510), vol. 1, no. 9, page e1500973-
EXAMINATION- Yann F. Mahe ET AL, "Androgenetic alopecia and microinflammation", INTERNATIONAL JOURNAL OF DERMATOLOGY, UK, (20000801), vol. 39, no. 8, doi:10.1046/j.1365-4362.2000.00612.x, ISSN 0011-9059, pages 576 - 584, XP055096339
EXAMINATION- Kerstin Foitzik ET AL, "Human Scalp Hair Follicles Are Both a Target and a Source of Prolactin, which Serves as an Autocrine and/or Paracrine Promoter of Apoptosis-Driven Hair Follicle Regression", AMERICAN JOURNAL OF PATHOLOGY., US, (20060301), vol. 168, no. 3, doi:10.2353/ajpath.2006.050468, ISSN 0002-9440, pages 748 - 756, XP055469860
INTERNATIONAL-SEARCH-REPORT- SUMMARY OF THE 2010 ALOPECIA AREATA CLINICAL/TRANSLATIONAL RESEARCH SUMMIT., (20101022), URL: http://www.naaf.org/site/PageServer?pagename=2010, (20120216), XP055106797-
SEARCH- DELAMERE F M ET AL, "Interventions for alopecia areata.", THE COCHRANE DATABASE OF SYSTEMATIC REVIEWS 2008, (2008), no. 2, ISSN 1469-493X, page CD004413, XP009182992 [A] 1-14 * page 8 * * page 16, paragraph 1 *-
SEARCH- CAILLAT-ZUCMAN ET AL, "How NKG2D Ligands Trigger Autoimmunity?", HUMAN IMMUNOLOGY, NEW YORK, NY, US, vol. 67, no. 3, doi:10.1016/J.HUMIMM.2006.02.013, ISSN 0198-8859, (20060301), pages 204 - 207, (20060301), XP024993277 [A] 1-14 * the whole document *
SEARCH- PETUKHOVA LYNN ET AL, "Genome-wide association study in alopecia areata implicates both innate and adaptive immunity.", NATURE 1 JUL 2010, (20100701), vol. 466, no. 7302, ISSN 1476-4687, pages 113 - 117, XP002736853 [A] 1-14 * the whole document *
SEARCH- HORNG TIFFANY ET AL, "NKG2D signaling is coupled to the interleukin 15 receptor signaling pathway.", NATURE IMMUNOLOGY DEC 2007, (200712), vol. 8, no. 12, ISSN 1529-2916, pages 1345 - 1352, XP002736855 [A] 1-14 * the whole document *
SEARCH- XING LUZHOU ET AL, "Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition", NATURE MEDICINE, (20140817), vol. 20, no. 9, ISSN 1078-8956, pages 1043 - 1049, XP002736857 [T] 1-14 * the whole document *
SEARCH- ITO TAISUKE ET AL, "Maintenance of hair follicle immune privilege is linked to prevention of NK cell attack.", THE JOURNAL OF INVESTIGATIVE DERMATOLOGY MAY 2008, (200805), vol. 128, no. 5, ISSN 1523-1747, pages 1196 - 1206, XP002736854 [A] 1-14 * the whole document *
SEARCH- HORDINSKY MARIA K, "Treatment of alopecia areata: "What is new on the horizon?".", DERMATOLOGIC THERAPY 2011 MAY-JUN, (201105), vol. 24, no. 3, ISSN 1529-8019, pages 364 - 368, XP002736856 [XP] 1,3-14 * page 367; table 3 *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents